book a demo
Home > About Us > Our leadership team
Driven to understand more about how proteins behave and function, but frustrated by the lack of suitable tools for protein characterisation – we’re building our own.
Chief Executive Officer
Andrew Lynn is an entrepreneur and executive with a focus on life-science and physical-science ventures. Andrew founded Orthomimetics, a regenerative orthopaedic devices company, based on his PhD research conducted jointly at the University of Cambridge and the Massachusetts Institute of Technology.
Founder and Chief Scientific Officer
Professor Knowles holds a personal Professorship in the Department of Chemistry and at the Cavendish Laboratory at the University of Cambridge and is also a Fellow of St John’s College Cambridge. His current research interests are focused on using physical approaches to study the self-assembly of protein molecules both in the context of biological function and malfunction.
Head of People
Chief Technology Officer
Interim Chief Financial Officer
Justine is an experienced, CIMA qualified Chief Financial Officer with extensive commercial and financial knowledge
Head of Quality & Regulatory
Liam’s background is in product development of medical devices and diagnostics and he has been specialising in the quality and regulatory aspects of new products since 2010.
Chief Product Officer
Heike is an executive leader with more than 20 years’ experience of Molecular Genetics, Diagnostics and Human Health.
Dr Joe Keegan is a respected international business leader with a successful track record spanning 30 years in the life-sciences industry.
Max is a Managing Partner at IQ Capital, a technology VC fund.
Dr Mike Evans is longtime senior executive and board member in the life sciences industry with a successful track record of transforming businesses and leading them to successful exits.
Dr Vishal Gulati is a Venture Partner at DFJ Esprit and one of the Europe’s leading digital healthcare investors.
Dr Ben Cons is a Pharmaceutical and Healthcare leader with a proven track record and more than 30 years experience in pharmaceutical R&D & commercialisation in the Biotech, Pharmaceutical and Financing sectors.